American Healthcare REIT (NYSE:AHR) Announces Quarterly Earnings Results

American Healthcare REIT (NYSE:AHR) released its quarterly earnings results on Thursday. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.02, FiscalAI reports. American Healthcare REIT had a return on equity of 3.33% and a net margin of 4.23%.The business had revenue of $445.63 million during the quarter, compared to analyst estimates of $645.30 million. During the same quarter in the previous year, the company posted $0.42 earnings per share. American Healthcare REIT’s revenue for the quarter was up 24.3% on a year-over-year basis. American Healthcare REIT updated its FY 2026 guidance to 2.150-2.190 EPS.

American Healthcare REIT Price Performance

Shares of NYSE:AHR traded up $1.53 during mid-day trading on Friday, reaching $56.24. The stock had a trading volume of 595,549 shares, compared to its average volume of 2,896,399. The business’s 50 day moving average price is $52.03 and its 200 day moving average price is $50.66. American Healthcare REIT has a 1 year low of $39.64 and a 1 year high of $58.70. The company has a market cap of $10.84 billion, a P/E ratio of 97.01, a price-to-earnings-growth ratio of 1.86 and a beta of 0.76. The company has a current ratio of 0.45, a quick ratio of 0.45 and a debt-to-equity ratio of 0.28.

American Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, July 17th. Investors of record on Tuesday, June 30th were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Tuesday, June 30th. American Healthcare REIT’s payout ratio is currently 172.41%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on AHR shares. KeyCorp boosted their price objective on American Healthcare REIT from $55.00 to $58.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. Scotiabank lowered their price target on shares of American Healthcare REIT from $59.00 to $51.00 and set a “sector outperform” rating on the stock in a report on Thursday, June 18th. UBS Group upped their price target on shares of American Healthcare REIT from $60.00 to $63.00 and gave the stock a “buy” rating in a research report on Wednesday, July 8th. Citigroup reissued an “outperform” rating on shares of American Healthcare REIT in a research note on Monday, July 27th. Finally, Royal Bank Of Canada upped their target price on shares of American Healthcare REIT from $54.00 to $56.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Twelve analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $58.83.

Insider Activity at American Healthcare REIT

In other American Healthcare REIT news, EVP Mark E. Foster sold 2,500 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $48.58, for a total transaction of $121,450.00. Following the completion of the transaction, the executive vice president owned 52,995 shares in the company, valued at $2,574,497.10. This trade represents a 4.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Brian Peay sold 25,000 shares of American Healthcare REIT stock in a transaction on Friday, June 26th. The stock was sold at an average price of $50.70, for a total transaction of $1,267,500.00. Following the completion of the transaction, the chief financial officer directly owned 152,700 shares of the company’s stock, valued at $7,741,890. The trade was a 14.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 29,500 shares of company stock worth $1,485,590 over the last ninety days. Insiders own 0.75% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in AHR. Smartleaf Asset Management LLC lifted its position in American Healthcare REIT by 960.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 3,437 shares of the company’s stock worth $164,000 after buying an additional 3,113 shares during the last quarter. CIBC Private Wealth Group LLC raised its stake in shares of American Healthcare REIT by 160.4% in the third quarter. CIBC Private Wealth Group LLC now owns 1,872 shares of the company’s stock valued at $79,000 after acquiring an additional 1,153 shares during the period. Advisory Services Network LLC purchased a new stake in shares of American Healthcare REIT in the third quarter valued at $101,000. Triumph Capital Management bought a new stake in shares of American Healthcare REIT in the 3rd quarter worth about $109,000. Finally, US Bancorp DE lifted its holdings in shares of American Healthcare REIT by 84.8% in the 3rd quarter. US Bancorp DE now owns 1,085 shares of the company’s stock worth $46,000 after acquiring an additional 498 shares during the last quarter. Hedge funds and other institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Company Profile

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.